Rao Mushtaq

Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation

Nicholas J. Thomas, Nathaniel J. Myall, Fangdi Sun et al. · Journal of Thoracic Oncology · 2021 · 112 citations · Full text

Medicine, Oncology, Radiation Oncology +12

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events

Terry L. Ng, Derek Smith, Rao Mushtaq et al. · Journal of Thoracic Oncology · 2018 · 74 citations

Medicine, Genetics, Molecular Genetics +9

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non–Small-Cell Lung Cancer

Tejas Patil, Rao Mushtaq, Sydney Marsh et al. · Clinical Lung Cancer · 2019 · 39 citations · Full text

Medicine, Genetics, Oncology +16

Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors

Jessica S.W. Borgers, Richard P. Tobin, Robert J. Torphy et al. · Journal of the National Comprehensive Cancer Network · 2021 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease

Susumu Inoue, Isra’a Khan, Rao Mushtaq et al. · Annals of Hematology · 2015 · 11 citations

Nursing, Emergency Medical Services, Emergency Medicine +12